NYSE - Delayed Quote • USD
West Pharmaceutical Services, Inc. (WST)
At close: April 25 at 4:02 PM EDT
Pre-Market: 8:10 AM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 9 | 9 |
| Avg. Estimate | 1.26 | 1.99 | 7.62 | 9.05 |
| Low Estimate | 1.2 | 1.87 | 7.5 | 8.54 |
| High Estimate | 1.34 | 2.1 | 7.89 | 9.5 |
| Year Ago EPS | 1.98 | 2.11 | 8.08 | 7.62 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 9 | 9 |
| Avg. Estimate | 670.3M | 759.25M | 3.01B | 3.28B |
| Low Estimate | 657.09M | 735M | 3B | 3.24B |
| High Estimate | 676.6M | 768.1M | 3.02B | 3.34B |
| Year Ago Sales | 698.19M | 755.71M | 2.95B | 3.01B |
| Sales Growth (year/est) | -4.00% | 0.50% | 2.10% | 9.10% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 1.67 | 1.93 | 1.86 | 1.78 |
| EPS Actual | 1.98 | 2.11 | 2.16 | 1.83 |
| Difference | 0.31 | 0.18 | 0.3 | 0.05 |
| Surprise % | 18.60% | 9.30% | 16.10% | 2.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 1.26 | 1.99 | 7.62 | 9.05 |
| 7 Days Ago | 1.26 | 1.99 | 7.62 | 9.05 |
| 30 Days Ago | 1.3 | 1.98 | 7.62 | 9.06 |
| 60 Days Ago | 1.3 | 1.98 | 7.61 | 9.05 |
| 90 Days Ago | 2.09 | 2.28 | 8.8 | 9.92 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | 1 | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | WST | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -36.40% | -- | -- | 2.60% |
| Next Qtr. | -5.70% | -- | -- | 13.40% |
| Current Year | -5.70% | -- | -- | 5.20% |
| Next Year | 18.80% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 7.64% | -- | -- | 11.11% |
| Past 5 Years (per annum) | 27.05% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
| Maintains | UBS: Neutral to Neutral | 2/16/2024 |
| Maintains | Keybanc: Overweight to Overweight | 2/13/2024 |
| Upgrade | Jefferies: Hold to Buy | 2/7/2024 |
| Maintains | Stephens & Co.: Overweight to Overweight | 10/27/2023 |
| Maintains | Keybanc: Overweight to Overweight | 8/30/2023 |
| Maintains | Keybanc: Overweight to Overweight | 8/21/2023 |
Related Tickers
RMD ResMed Inc.
183.42
-0.20%
BDX Becton, Dickinson and Company
230.48
-1.43%
RGEN Repligen Corporation
165.66
-1.31%
TFX Teleflex Incorporated
206.71
-2.11%
ATR AptarGroup, Inc.
140.18
+0.12%
COO The Cooper Companies, Inc.
89.93
-0.30%
STVN Stevanato Group S.p.A.
27.52
+0.77%
UTMD Utah Medical Products, Inc.
66.29
-1.30%
SRT3.DE Sartorius Aktiengesellschaft
287.80
+2.02%
HOLX Hologic, Inc.
75.71
-1.30%